Effects of Movement Retraining on Knee Loading in Individuals With Knee Osteoarthritis

April 16, 2024 updated by: Scott Delp, Stanford University

Effects of Haptic Movement Retraining on Osteoarthritis Progression

This study investigates how well individuals with knee osteoarthritis can learn to alter their calf muscle activation using haptic biofeedback while walking and evaluates how these changes affect knee loading.

Prior research has utilized musculoskeletal simulations to determine that reducing the activation of one of the calf muscles, the gastrocnemius, can have a large impact on reducing knee loading. However, this has not been tested in individuals with knee osteoarthritis. In this study, participants will be trained to alter the activation of their gastrocnemius muscle, by receiving haptic feedback after each step. The feedback will indicate how the participant changed their muscle activation relative to baseline. Participants will train for up to three sessions, with 30 minutes of walking with feedback in each session. If a participant can learn to adjust their muscle activation in the first training session, they will be able to complete the second training session. An exploratory third session may be conducted to investigate changes in knee loading while using the new walking strategy during over-ground walking.

The movement data collected during the training sessions will be used as inputs to computer simulations of the musculoskeletal system to determine if walking with the new muscle activation strategy reduces knee loading.

Study Overview

Status

Recruiting

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

13

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Medial and/or lateral compartment knee osteoarthritis
  • Diagnosed with knee osteoarthritis of at least six months duration
  • Ambulatory without aids
  • Able to walk for at least 60 minutes
  • Typical pain rating less than or equal to 4 on scale of 0-10
  • Able to reduce gastrocnemius muscle activation by 10% from baseline

Exclusion Criteria:

  • History of symptomatic arthritis in lower limb joints other than the knees
  • Replacement of any lower extremity joint
  • Symptoms originating from the patellofemoral joint
  • Body mass index equal to or greater than 35
  • Nerve or muscle disease associated with walking difficulty
  • History of rheumatoid arthritis, gout, or autoimmune disease
  • History of lower limb fracture or surgery requiring hospitalization
  • Pregnant
  • Severe knee malalignment, defined as a hip-knee-ankle angle of more than 5 degrees from neutral
  • Recurrent giving way of the knee

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Gait modification
Participants will learn to change muscle coordination while walking through real-time haptic biofeedback based on the activation of the gastrocnemius muscle
Changing muscle coordination while walking

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from baseline in knee contact force
Time Frame: Evaluated during the second session of up to 30 minutes of gait retraining
Knee contact force will be evaluated using motion capture data and musculoskeletal modeling and simulations, for participants that are able to reduce gastrocnemius activation.
Evaluated during the second session of up to 30 minutes of gait retraining

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from baseline in gastrocnemius activation
Time Frame: Evaluated during first session of up to 30 minutes of gait retraining and the second session of up to 30 minutes of gait retraining
Gastrocnemius activation measured through EMG signals.
Evaluated during first session of up to 30 minutes of gait retraining and the second session of up to 30 minutes of gait retraining
Proportion of participants that reduce gastrocnemius activation
Time Frame: Evaluated during first session of up to 30 minutes of gait retraining and the second session of up to 30 minutes of gait retraining
Gastrocnemius activation will be measured through electromyography (EMG) signals, and the muscle activation during gait retraining will be compared to baseline walking. Participants that can reduce gastrocnemius activation 10% or more from baseline within 30 minutes of gait retraining will be counted as participants that can reduce gastrocnemius activation out of the total number of participants who try the gait retraining.
Evaluated during first session of up to 30 minutes of gait retraining and the second session of up to 30 minutes of gait retraining
Proportion of participants that reduce knee contact force
Time Frame: Evaluated during the second session of up to 30 minutes of gait retraining
For the participants who can successfully reduce gastrocnemius activation from baseline, knee contact force will be calculated using motion capture data and musculoskeletal modeling and simulations. The proportion of participants that reduce knee contact force from baseline during gait retraining out of the total participants that reduce gastrocnemius activation will be evaluated.
Evaluated during the second session of up to 30 minutes of gait retraining

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Scott L Delp, PhD, Stanford University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 18, 2024

Primary Completion (Estimated)

December 1, 2024

Study Completion (Estimated)

December 1, 2024

Study Registration Dates

First Submitted

December 18, 2023

First Submitted That Met QC Criteria

January 6, 2024

First Posted (Actual)

January 17, 2024

Study Record Updates

Last Update Posted (Actual)

April 18, 2024

Last Update Submitted That Met QC Criteria

April 16, 2024

Last Verified

April 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • 34928

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

De-identified experimental data and simulation results will be made available.

IPD Sharing Time Frame

After publication and no end date

IPD Sharing Access Criteria

Data will be publicly available online at SimTK.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Osteoarthritis, Knee

Clinical Trials on Gait retraining

3
Subscribe